Pharma channel feed

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

Last month
People

FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval

Last month
FDA+
Coronavirus

Reper­toire inks au­toim­mune deal with Genen­tech as it eyes a re­turn to the clin­ic

Last month
Startups
Deals

Eli Lil­ly sues four tele­health com­pa­nies sell­ing com­pound­ed tirzepatide

Last month
Law
Health Tech

Bris­tol My­er­s' schiz­o­phre­nia drug fails Phase 3 tri­al for ad­junc­tive treat­ment

Last month
R&D

Vac­cine biotechs say they’ve been told to stop next-gen Covid work un­der a Biden-era project

Last month
Coronavirus

As­traZeneca re­joins PhRMA, two years af­ter leav­ing lob­by group

Last month

Re­gen­eron to boost its US man­u­fac­tur­ing through a $3B Fu­ji­film deal

Last month
Manufacturing

Drug­mak­ers stock­pile in­ven­to­ry in the US, seek­ing to get ahead of Trump tar­iffs

Last month
China
Manufacturing

Up­dat­ed: Roche’s $50B US in­vest­ment in­cludes pre­vi­ous build an­nounce­ments

Last month
Manufacturing

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

Last month
R&D

Alvo­gen unit ap­peals court loss shield­ing Bausch Health's IBS drug from gener­ics

Last month
FDA+
Law

GSK kicks off Blenrep re­launch plans with clear­ance from UK reg­u­la­tors

Last month
FDA+

CMS would ab­sorb 340B drug dis­count pro­gram un­der leaked HHS re­or­ga­ni­za­tion pro­pos­al

Last month
FDA+

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Last month
Manufacturing

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

Last month
FDA+
Law

Biotechs start to dis­close tar­iff ex­po­sure with US trade in­quiry un­der­way 

Last month
Manufacturing

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

Last month
FDA+

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

Last month
Law

Leqem­bi wins EU au­tho­riza­tion for some Alzheimer's pa­tients, giv­ing Bio­gen, Ei­sai a boost over Lil­ly

Last month
FDA+

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Last month
Manufacturing

Con­gress should bar PBMs from own­ing phar­ma­cies, state at­tor­neys urge

Last month

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

Last month
Manufacturing

J&J, phar­ma's earn­ings bell­wether, main­tains guid­ance as tar­iffs loom

Last month
First page Previous page 45678910 Next page Last page
A service from the Financial Times